| Pleiotropic roles of ABC transporters in breast cancer J He, E Fortunati, DX Liu, Y Li International Journal of Molecular Sciences 22 (6), 3199, 2021 | 49 | 2021 |
| SPAG5: an emerging oncogene J He, AR Green, Y Li, SYT Chan, DX Liu Trends in Cancer 6 (7), 543-547, 2020 | 32 | 2020 |
| Transport-mediated oxaliplatin resistance associated with endogenous overexpression of MRP2 in Caco-2 and PANC-1 cells R Biswas, P Bugde, J He, F Merien, J Lu, DX Liu, K Myint, J Liu, ... Cancers 11 (9), 1330, 2019 | 19 | 2019 |
| Emerging intrinsic therapeutic targets for metastatic breast cancer J Li, ELK Goh, J He, Y Li, Z Fan, Z Yu, P Yuan, DX Liu Biology 12 (5), 697, 2023 | 10 | 2023 |
| Application of CRISPR-Cas9 System to study biological barriers to drug delivery J He, R Biswas, P Bugde, J Li, DX Liu, Y Li Pharmaceutics 14 (5), 894, 2022 | 4 | 2022 |
| Aidi injection, a traditional Chinese medicine extract, reverses Gefitinib resistance in non-small cell lung cancer cells R Biswas, C Yang, W Lu, J He, T Chen, F Tian, Y Li European Journal of Integrative Medicine 46, 101368, 2021 | 3 | 2021 |
| Multidrug resistance protein 5 affects cell proliferation, migration and gemcitabine sensitivity in pancreatic cancer MIA Paca‑2 and PANC‑1 cells J He, P Bugde, J Li, R Biswas, S Li, X Yang, F Tian, Z Wu, Y Li Oncology Reports 51 (1), 7, 2023 | 2 | 2023 |
| Sperm-Associated Antigen 5 Knockout Reduces Doxorubicin and Docetaxel Resistance in Triple-Negative Breast Cancer MDA-MB-231 and BT549 Cells J He, J Li, Y Liu, Y Li Cancers 16 (7), 1269, 2024 | | 2024 |
